Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis
Authors
Keywords
-
Journal
GENETICS IN MEDICINE
Volume 17, Issue 10, Pages 789-795
Publisher
Springer Nature
Online
2015-01-09
DOI
10.1038/gim.2014.192
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
- (2014) J Athene Lane et al. LANCET ONCOLOGY
- Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
- (2013) Virginia A. Moyer ANNALS OF INTERNAL MEDICINE
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array
- (2013) Rosalind A Eeles et al. NATURE GENETICS
- The genetic epidemiology of prostate cancer and its clinical implications
- (2013) Rosalind Eeles et al. Nature Reviews Urology
- Personalized screening for cancers: should we consider polygenic profiling?
- (2013) Nora Pashayan et al. Personalized Medicine
- Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
- (2012) G. L. Andriole et al. JNCI-Journal of the National Cancer Institute
- Risk stratification in prostate cancer screening
- (2012) Monique J. Roobol et al. Nature Reviews Urology
- Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
- (2011) N Pashayan et al. BRITISH JOURNAL OF CANCER
- Individual and cumulative association of prostate cancer susceptibility variants with clinicopathologic characteristics of the disease
- (2010) Bo-Ying Bao et al. CLINICA CHIMICA ACTA
- Lead-time in the European Randomised Study of Screening for Prostate Cancer
- (2010) Patrik Finne et al. EUROPEAN JOURNAL OF CANCER
- High-throughput single nucleotide polymorphism genotyping using nanofluidic Dynamic Arrays
- (2009) Jun Wang et al. BMC GENOMICS
- Mean sojourn time, overdiagnosis and reduction in advanced stage prostate cancer due to screening with PSA: implications of sojourn time on screening
- (2009) N Pashayan et al. BRITISH JOURNAL OF CANCER
- Association of Prostate Cancer Risk Variants with Clinicopathologic Characteristics of the Disease
- (2008) J. Xu et al. CLINICAL CANCER RESEARCH
- Cumulative Association of Five Genetic Variants with Prostate Cancer
- (2008) S. Lilly Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started